TFAP2A promotes NSCLC malignant progression by enhancing AOC1 transcription
Silencing TFAP2A inhibits NSCLC progression via regulating AOC1 transcription. Hence, AOC1/TFAP2A may be a feasible therapeutic target for NSCLC.
Authors
- Jing Chang (ORCID: https://orcid.org/0000-0001-7366-8317)
- Huimin Mo
- Qin Jia
- Hong-Zhen Zheng
- Xiang Miao (ORCID: https://orcid.org/0000-0002-1577-1698)
- Hai Zhou
Institutions
- YangPu Geriatric Hospital (CN)
- Yangpu Hospital of Tongji University (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1186/s41065-025-00524-2
- Citations
- 3
- Primary Topic
- Polyamine Metabolism and Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- Science and Technology Commission of Shanghai Municipality
- National Health Commission of the People's Republic of China